Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Zika Virus Inactivated in Plasma for Transfusion

By LabMedica International staff writers
Posted on 03 Apr 2016
The potential for Zika virus (ZIKV) transmission through blood transfusion has been demonstrated during the French Polynesian outbreak as 2.8% of blood donors, who were asymptomatic at the time of donation, were found positive for acute ZIKV infection using specific reverse transcription–polymerase chain reaction (RT-PCR).

Several processes have been developed for the inactivation of pathogens during the preparation of fresh-frozen plasma (FFP) and platelet (PLT) concentrates. Among them, a photochemical treatment using the psoralen, amotosalen, S-59, in combination with ultraviolet A (UVA) illumination, has been shown to inactivate a broad range of viruses, bacteria, and protozoans.

A team of scientists working with those at the Institut Louis Malardé (Papeete, Tahiti, French Polynesia) collected plasma units from USA blood donors to eliminate risk of ZIKV antibodies. To assess the absence of previous infections by Flaviviruses known to circulate in the USA, Dengue and West Nile (DENV and WNV), each plasma unit was tested with a dengue immunoglobulin (Ig)G capture kit (Platelia, Bio-Rad; Hercules, CA, USA) and a classic WNV IgG kit (Serion Elisa, Abcam; Cambridge, UK), to detect IgG antibodies against DENV and WNV, respectively. The 26 sera of French Polynesian ZIKV-infected and asymptomatic blood donors were obtained from the blood bank center of French Polynesia.

Four plasma units (A, B, C, and D) were inoculated with ZIKV. A sample from each infected plasma unit (pre-inactivation sample) was then collected and stored at -80 °C until the determination of viral titers and RNA loads. Inoculated Plasma Units A, B, and C were treated with amotosalen combined with UVA illumination, whereas inoculated Plasma Unit D was not inactivated and was the positive control. After transfer into a container with a compound absorption device that removes the residual amotosalen and the free photoproducts, samples from each inactivated plasma unit (inactivated samples) and from the positive control (non-inactivated sample) were collected and stored at -80 °C until the determination of viral titers and RNA loads.

For the detection of replicative ZIKV, all pre-, post-, and non-inactivated samples were inoculated in triplicate on VERO cells in 24-well plates, and five successive passages were performed. After each passage, indirect immunofluorescence assay was performed to detect ZIKV inoculated cells, using anti-flavivirus mouse antibodies 4G2. For all plasma (pre-, post-, and non-inactivated samples), cell supernatant, and serum samples, RNA extraction was performed using an extraction system and real-time RT-PCR was performed in a Bio-Rad CFX96 thermocycler.

The mean ZIKV titers and RNA loads in plasma before inactivation were respectively 6.57 log 50% tissue culture infectious dose (TCID50)/mL and 10.25 log copies/mL. After inactivation, the mean ZIKV RNA loads was 9.51 log copies/mL, but cell cultures inoculated with inactivated plasma did not result in infected cells and did not produce any replicative virus after one passage, nor detectable viral RNA from the second passage. The authors concluded that amotosalen combined with UVA light inactivates ZIKV in fresh-frozen plasma. This inactivation process is of particular interest to prevent plasma transfusion-transmitted ZIKV infections in areas such as French Polynesia, where several arboviruses are co-circulating. The study was published in the January 2016 issue of the journal Transfusion.

Related Links:

Institut Louis Malardé
Bio-Rad 
Abcam 



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Silver Member
HPV Molecular Controls
ZeptoMetrix® HPV Type 16, 18, 45 & 68 Molecular Controls
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.